How is more negative evidence being used to support claims of benefit: The curious case of the third international stroke trial (IST-3)

Editorial

Jerome R Hoffman et al. Emerg Med Australas. 2012 Oct.

. 2012 Oct;24(5):473-6.

doi: 10.1111/j.1742-6723.2012.01604.x.

No abstract available

Comment in

Stroke thrombolysis and the third international stroke trial: examining 'the totality of the evidence'.
Kleinig TJ, Churilov L, Parsch CS, Dewey HM, Barber PA. Kleinig TJ, et al. Emerg Med Australas. 2013 Apr;25(2):107-9. doi: 10.1111/1742-6723.12046. Emerg Med Australas. 2013. PMID: 23560957 No abstract available.
Stroke thrombolysis: leaving the past, understanding the present and moving forward ….
Bladin C, Levi C, Parsons M. Bladin C, et al. Emerg Med Australas. 2013 Apr;25(2):195-6. doi: 10.1111/1742-6723.12025. Emerg Med Australas. 2013. PMID: 23560973 No abstract available.
Response from Drs Hoffman and Cooper to Stroke thrombolysis: Leaving the past, understanding the present and moving forward ….
Hoffman JR, Cooper RJ. Hoffman JR, et al. Emerg Med Australas. 2013 Apr;25(2):197-8. doi: 10.1111/1742-6723.12056. Emerg Med Australas. 2013. PMID: 23560975 No abstract available.